| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 1527 |
| 1 | ADALIMUMAB | 603 |
| 2 | DULAGLUTIDE | 363 |
| 3 | ETANERCEPT | 311 |
| 4 | INSULIN GLARGINE | 279 |
| 5 | GALCANEZUMAB-GNLM | 204 |
| 6 | METFORMIN | 184 |
| 7 | METFORMIN ER 500 MG | 181 |
| 8 | METFORMIN ER 750 MG | 181 |
| 9 | TERIPARATIDE | 175 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRALIDOXIME CHLORIDE | 4 | 0.1538 |
| 1 | TIRZEPATIDE | 1527 | 0.0084 |
| 2 | ADALIMUMAB-ADBM | 2 | 0.0075 |
| 3 | GALCANEZUMAB-GNLM | 204 | 0.0063 |
| 4 | TESTOSTERONE ENANTHATE | 8 | 0.0049 |
| 5 | DULAGLUTIDE | 363 | 0.0041 |
| 6 | PEGVISOMANT | 16 | 0.0039 |
| 7 | ADALIMUMAB-ATTO | 4 | 0.0025 |
| 8 | ERGOCALCIFEROL | 65 | 0.0022 |
| 9 | BETAMETHASONE VALERATE FOAM | 9 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 1956 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1527 |
| 2 | Insulin Analog [EPC] | 437 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 364 |
| 4 | Parathyroid Hormone Analog [EPC] | 175 |
| 5 | PCSK9 Inhibitor [EPC] | 172 |
| 6 | Interferon beta [EPC] | 133 |
| 7 | Interleukin-17A Antagonist [EPC] | 129 |
| 8 | Catecholamine [EPC] | 114 |
| 9 | alpha-Adrenergic Agonist [EPC] | 114 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 1 | PCSK9 Inhibitor [EPC] | 172 | 0.0067 |
| 2 | GLP-1 Receptor Agonist [EPC] | 1956 | 0.0044 |
| 3 | Interleukin-17A Antagonist [EPC] | 129 | 0.0035 |
| 4 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 5 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 6 | Provitamin D2 Compound [EPC] | 65 | 0.0022 |
| 7 | Parathyroid Hormone Analog [EPC] | 175 | 0.0016 |
| 8 | Catecholamine [EPC] | 114 | 0.0014 |
| 9 | Insulin [EPC] | 63 | 0.0014 |